TIMP1 protects against blood-brain barrier disruption after subarachnoid haemorrhage by inhibiting ubiquitination of astrocytic β1-integrin

Tianchi Tang,Huaijun Chen,Libin Hu,Jingya Ye,Chaohui Jing,Chaoran Xu,Xinyan Wu,Yike Chen,Zihang Chen,Hang Zhou,Linfeng Fan,Xiongjie Fu,Cong Qian,Jingsen Chen,Zhongju Tan,Jing Liu,Hanhai Zeng,Gao Chen,Fuyi Liu

DOI: https://doi.org/10.1136/svn-2023-002956

IF: 5.9

2024-03-14

Stroke and Vascular Neurology

Abstract:Background Astrocytes regulate blood-brain barrier (BBB) integrity, whereas subarachnoid haemorrhage (SAH) results in astrocyte dysregulation and BBB disruption. Here, we explored the involvement of tissue inhibitor of matrix metalloprotease-1 (TIMP1) in astrocyte-mediated BBB protection during SAH, along with its underlying mechanisms. Methods C57BL/6J mice were used to establish a model of SAH. The effects of TIMP1 on SAH outcomes were analysed by intraperitoneal injection of recombinant mouse TIMP1 protein (rm-TIMP1; 250 μg/kg). The roles of TIMP1 and its effector β1-integrin on astrocytes were observed by in vivo transduction with astrocyte-targeted adeno-associated virus carrying TIMP1 overexpression plasmid or β1-integrin RNAi. The molecular mechanisms underlying TIMP1 and β1-integrin interactions were explored in primary cultured astrocytes stimulated with red blood cells (RBCs). Results TIMP1 was upregulated after SAH. Administration of rm-TIMP1 mitigated SAH-induced early brain injury (EBI) in male and female mice. TIMP1 was primarily expressed in astrocytes; its overexpression in astrocytes led to increased β1-integrin expression in astrocytes, along with the preservation of astrocytic endfoot attachment to the endothelium and subsequent recovery of endothelial tight junctions. All of these effects were reversed by the knockdown of β1-integrin in astrocytes. Molecular analysis showed that TIMP1 overexpression decreased the RBC-induced ubiquitination of β1-integrin; this effect was partially achieved by inhibiting the interaction between β1-integrin and the E3 ubiquitin ligase Trim21. Conclusion TIMP1 inhibits the interaction between β1-integrin and Trim21 in astrocytes, thereby rescuing the ubiquitination of astrocytic β1-integrin. It subsequently restores interactions between astrocytic endfeet and the endothelium, as well as BBB integrity, eventually mitigating SAH-induced EBI.

clinical neurology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **The mechanism of blood - brain barrier (BBB) disruption after subarachnoid hemorrhage (SAH) and its potential therapeutic targets**.

Specifically, the authors explored **The role of tissue inhibitor of metalloproteinase 1 (TIMP1) in protecting the blood - brain barrier after SAH and its molecular mechanism**. The study found that TIMP1 prevents the degradation of β1 - integrin in astrocytes by inhibiting its ubiquitination, thereby maintaining the adhesion between astrocyte foot processes and endothelial cells and ultimately restoring the integrity of the blood - brain barrier. This process involves inhibiting the interaction between β1 - integrin and the E3 ubiquitin - ligase Trim21.

### Main problems and solutions
1. **Problem: SAH leads to early brain injury (EBI), and one of the important mechanisms is the disruption of the blood - brain barrier.**
- **Solution: The study found that TIMP1 can protect the blood - brain barrier by inhibiting the ubiquitination of β1 - integrin.**

2. **Problem: There is currently a lack of effective treatment methods to maintain the blood - brain barrier and reduce early brain injury after SAH.**
- **Solution: The study revealed the possibility of TIMP1 as a potential therapeutic target, providing a theoretical basis for the development of new treatment strategies.**

### Main contributions of the study
- **It was found that TIMP1 is up - regulated after SAH, and exogenous administration of recombinant TIMP1 can significantly reduce early brain injury.**
- **The molecular mechanism by which TIMP1 maintains the integrity of the blood - brain barrier by inhibiting the ubiquitination of β1 - integrin in astrocytes was elucidated.**
- **TIMP1 was proposed as a new target for SAH treatment, which has important clinical application prospects.**

### Conclusion
This study shows that TIMP1 reduces the degradation of β1 - integrin by inhibiting its ubiquitination in astrocytes, thereby restoring the adhesion between astrocyte foot processes and endothelial cells, and ultimately protecting the integrity of the blood - brain barrier and reducing early brain injury after SAH. This finding provides new ideas and potential targets for the treatment of SAH.

### Formula presentation
The ubiquitination reactions involved in the article can be represented by the following formulas:

\[ \text{Ubiquitination of } \beta_1\text{-integrin} \rightarrow \text{Proteasome degradation} \]

\[ \text{TIMP1 inhibits the ubiquitination of } \beta_1\text{-integrin by interfering with its interaction with Trim21} \]

These formulas show the process of β1 - integrin being degraded by the proteasome after ubiquitination, and how TIMP1 inhibits this process by interfering with the interaction between β1 - integrin and Trim21.